Low levels of vitamin D are associated with all-cause dementia, including Alzheimer’s disease (AD), according to the largest multicenter population study published Aug. 6 in Neurology. 

More than $300,000 will go toward genomic research by African investigators carried out in Africa, according to an announcement Aug. 3 from the National Institutes of Health (NIH).

A round up of genomics research is presented in this Telegraph anthology of recent articles from international news sources. Millions of dollars are being funneled into a project to "unlock"  DNA, personal genomics could become second nature, and challenges that have held up the science of genomics and its applications are presented.

A high uptake of FDG could signal glucose hypermetabolism in muscle, making FDG PET a novel addition to more conventional methods of detecting denervation, according to a study published Aug. 7 in the Journal of Nuclear Medicine.

Varian Medical Systems announced Aug. 5 that the company acquired dose calculation software produced by Transpire to merge with treatment planning technology.

Since the U.S. Preventive Services Task Force released mammography recommendations in 2009 that did not include routine screening for women 75 and older, there has been much debate over the benefits of screening in older women. One of the main sticking points for those reluctant to recommend screening in this population is a lack of evidence.

The FDA has announced that more than 11,000 lab-driven diagnostic tests that have never been regulated will now fall under the agency's oversight. This includes cancer screening and genetic testing, an area of research that has exploded in the past couple of decades.

The glutamate receptor is an important player in nerve signaling and exceptionally high-resolution images of protein interactions are revealing how these receptors operate, which could have an impact on future targets for a wide variety of neurodegenerative diseases, announced the National Institutes of Health (NIH) on Monday.